Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings
NCT ID: NCT02837536
Last Updated: 2017-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
107 participants
INTERVENTIONAL
2016-06-23
2016-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraocular Pressure During Robotic Assisted Laparoscopic Procedures Utilizing Steep Trendelenburg Positioning
NCT01261871
IOP Monitoring After Trabeculectomy Using iCare Home
NCT03445806
Home Tonometry With the I-care Tonometer for Glaucoma
NCT02656836
ICare Self-tonometry - A Head-to-head Comparison to the Gold Standard Goldmann Tonometer
NCT01733550
Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma
NCT02868502
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Horizontal iCare
In the horizontal iCare arm, these patients were randomized to have their IOP measured with the iCare tonometer held in the horizontal position first and then their IOP measured with the iCare tonometer held in the vertical position.
Horizontal iCare
IOP of the right eye will be measured using the iCare tonometer held in the horizontal position first and then in the vertical position.
Vertical iCare
IOP of the right eye will be measured using the iCare tonometer held in the vertical position first and then in the horizontal position.
Vertical iCare
In the vertical iCare arm, these patients were randomized to have their IOP measured with the iCare tonometer held in the vertical position first and then their IOP measured with the iCare tonometer held in the horizontal position.
Horizontal iCare
IOP of the right eye will be measured using the iCare tonometer held in the horizontal position first and then in the vertical position.
Vertical iCare
IOP of the right eye will be measured using the iCare tonometer held in the vertical position first and then in the horizontal position.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Horizontal iCare
IOP of the right eye will be measured using the iCare tonometer held in the horizontal position first and then in the vertical position.
Vertical iCare
IOP of the right eye will be measured using the iCare tonometer held in the vertical position first and then in the horizontal position.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be able to understand and sign and informed consent form that has been approved by an Institutional Review Board/Ethics Committee
Exclusion Criteria
* Use of topical ophthalmic medications (except for artificial tears)
* History or corneal surgeries
* Any condition that would prevent or inhibit intraocular pressure measurements using iCare or pneumotonometry
* Evidence of ocular infection 30 days prior to enrollment
* Allergy to proparacaine or latex
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Robert Cizik Eye Clinic
OTHER
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Feldman
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert M. Feldman, M.D.
Role: PRINCIPAL_INVESTIGATOR
Robert Cizik Eye Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert Cizik Eye Clinic
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-16-0396
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.